Ultrasound Classification of Finger Pulp Blood Flow in Patients With Systemic Sclerosis: A Pilot Study

To define a semiquantitative classification of finger pulp blood flow (FPBF) and to evaluate whether this classification could be used to assess FPBF in healthy controls and in systemic sclerosis (SSc) patients.

[1]  G. Mahé,et al.  Performance of finger systolic blood pressure measurement to detect digital occlusive arterial disease in systemic sclerosis. , 2021, Rheumatology.

[2]  L. Chung,et al.  Ultrasound evaluation of the hands and wrists in patients with systemic sclerosis: Osteophytosis is a major contributor to tender joints. , 2021, Seminars in arthritis and rheumatism.

[3]  J. Varga,et al.  New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine , 2021, Expert opinion on investigational drugs.

[4]  D. Khanna,et al.  How do patients define Raynaud’s phenomenon? Differences between primary and secondary disease , 2021, Clinical Rheumatology.

[5]  G. Burmester,et al.  The first composite score predicting Digital Ulcers in systemic sclerosis patients using Clinical data, Imaging and Patient history—CIP-DUS , 2020, Arthritis Research & Therapy.

[6]  L. Chung,et al.  Ultrasound Detection of Calcinosis and Association With Ulnar Artery Occlusion in Patients With Systemic Sclerosis , 2020, Arthritis care & research.

[7]  M. Rossini,et al.  Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients , 2020, International journal of rheumatic diseases.

[8]  C. Denton,et al.  Raynaud phenomenon and digital ulcers in systemic sclerosis , 2020, Nature Reviews Rheumatology.

[9]  A. Iagnocco,et al.  Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. , 2020, Autoimmunity reviews.

[10]  L. Mouthon,et al.  Psychometric validation of the Hand Disability in Systemic Sclerosis-Digital Ulcers (HDISS-DU®) patient-reported outcome instrument , 2020, Arthritis Research & Therapy.

[11]  D. Khanna,et al.  Drug initiation and escalation strategies of vasodilator therapies for Raynaud's phenomenon: can we treat to target? , 2019, Rheumatology.

[12]  J. Pope,et al.  Raynaud’s phenomenon—an update on diagnosis, classification and management , 2019, Clinical Rheumatology.

[13]  C. Cazalets,et al.  Ulnar Artery Occlusion and Severity Markers of Vasculopathy in Systemic Sclerosis: A Multicenter Cross‐Sectional Study , 2019, Arthritis & rheumatology.

[14]  G. Burmester,et al.  Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis , 2019, Arthritis Research & Therapy.

[15]  E. Hachulla,et al.  Imaging in Systemic Sclerosis: Make “US” Great Again? Comment on the Article by Santiago et al , 2019, Arthritis care & research.

[16]  M. Cutolo,et al.  Ultrasonography for the Assessment of Skin in Systemic Sclerosis: A Systematic Review , 2019, Arthritis care & research.

[17]  P. Boracchi,et al.  Evidence of macro- and micro-angiopathy in scleroderma: An integrated approach combining 22-MHz power Doppler ultrasonography and video-capillaroscopy. , 2019, Microvascular research.

[18]  P. Tugwell,et al.  OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies , 2019, The Journal of Rheumatology.

[19]  P. Boracchi,et al.  Acute and chronic effects of two different intravenous iloprost regimens in systemic sclerosis: a pragmatic non-randomized trial , 2018, Rheumatology.

[20]  C. Cazalets,et al.  Synovial involvement assessed by power Doppler ultra-sonography in systemic sclerosis: results of a cross-sectional study , 2018, Rheumatology.

[21]  Ankoor S. Shah,et al.  Patient-reported outcome instruments for assessing Raynaud’s phenomenon in systemic sclerosis: A SCTC vascular working group report , 2018, Journal of scleroderma and related disorders.

[22]  John Allen,et al.  A Multicenter Study of the Validity and Reliability of Responses to Hand Cold Challenge as Measured by Laser Speckle Contrast Imaging and Thermography , 2018, Arthritis & rheumatology.

[23]  C. Cazalets,et al.  Combination of Capillaroscopic and Ultrasonographic Evaluations in Systemic Sclerosis: Results of a Cross‐Sectional Study , 2018, Arthritis care & research.

[24]  G. Burmester,et al.  Detection of severe digital vasculopathy in systemic sclerosis by colour Doppler sonography is associated with digital ulcers , 2017, Rheumatology.

[25]  A. Iagnocco,et al.  The 2017 EULAR standardised procedures for ultrasound imaging in rheumatology , 2017, Annals of the rheumatic diseases.

[26]  M. Richard,et al.  Controlling the digital ulcerative disease in systemic sclerosis is associated with improved hand function. , 2017, Seminars in arthritis and rheumatism.

[27]  C. Cazalets,et al.  Vascular Evaluation of the Hand by Power Doppler Ultrasonography and New Predictive Markers of Ischemic Digital Ulcers in Systemic Sclerosis: Results of a Prospective Pilot Study , 2017, Arthritis care & research.

[28]  F. Spertini,et al.  Nailfold Videocapillaroscopic Features and Other Clinical Risk Factors for Digital Ulcers in Systemic Sclerosis: A Multicenter, Prospective Cohort Study , 2016, Arthritis & rheumatology.

[29]  Dual and Dual Investigators,et al.  Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials. , 2016, JAMA.

[30]  R. Jaussaud,et al.  Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study , 2015, Annals of the rheumatic diseases.

[31]  F. Batteux,et al.  Macro- and microvascular disease in systemic sclerosis. , 2015, Vascular pharmacology.

[32]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[33]  M. Matucci-Cerinic,et al.  Review: evidence that systemic sclerosis is a vascular disease. , 2013, Arthritis and rheumatism.

[34]  J. Michalek,et al.  A multi-centre, blinded, randomised, placebo-controlled, laboratory-based study of MQX-503, a novel topical gel formulation of nitroglycerine, in patients with Raynaud phenomenon , 2012, Annals of the rheumatic diseases.

[35]  M. McHugh.  Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[36]  D. Dragun,et al.  Ulnar artery occlusion is predictive of digital ulcers in SSc: a duplex sonography study. , 2012, Rheumatology.

[37]  M. Mayes,et al.  Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial , 2010, Annals of the rheumatic diseases.

[38]  M. Mayes,et al.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. , 2004, Arthritis and rheumatism.

[39]  R. Hauck,et al.  Pulp Nonfiction: Microscopic Anatomy of the Digital Pulp Space , 2004, Plastic and reconstructive surgery.

[40]  L. Kaufman,et al.  Intravenous Iloprost Infusion in Patients with Raynaud Phenomenon Secondary to Systemic Sclerosis: A Multicenter, Placebo-controlled, Double-Blind Study , 1994, Annals of Internal Medicine.

[41]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[42]  N Rowell,et al.  Systemic sclerosis. , 1968, British medical journal.